With 20+ years industry experience, Aman Khera discusses the importance of recruiting an inclusive patient population.

This playbook will look at the evolving challenges confronting biopharma CEOs today and share lessons learned from executives who are navigating some of these waters.

Building on the known to overcome the novel unknown. Read Worldwide’s take on the history of medicine and the development of the coronavirus vaccine.

This white paper explores the pros and cons of utilizing the non-traditional approach of an external control in your clinical trial.

Aman Khera discusses her nomination to the TOPRA Board. Listen to the podcast to learn more about TOPRA and her new position.

In this article Aman Khera and Tom Zietlow from Kineticos discuss how COVID-19 has changed perceptions of clinical research and what that means for the industry moving forward.